Straits Times Index
3,340.37 +9.56 (+0.29%) Nikkei
38,646.30 -57.21 (-0.15%) Hang Seng
18,565.51 +88.71 (+0.48%) FTSE 100
8,285.34 +38.39 (+0.47%) Bitcoin USD
70,874.96 -280.44 (-0.39%) CMC Crypto 200
1,474.43 -50.38 (-3.30%)
CLGN Oct 2024 5.000 put
| Previous close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.0000 |
| Ask | 1.2000 |
| Strike | 5.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.6000 - 0.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
PR NewswireCollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen) for tissue regeneration and organ manufacturing, today announced that it has successfully printed for the first-time breast implants of 200 cc, which are commercial size. These implants were printed using CollPlant's proprietary rhCollagen bioinks. In addition, CollPlant announced additiona
Simply Wall St.CollPlant Biotechnologies First Quarter 2024 Earnings: Misses Expectations
CollPlant Biotechnologies ( NASDAQ:CLGN ) First Quarter 2024 Results Key Financial Results Revenue: US$98.0k (down 77...
PR NewswireCollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced results for the first quarter ended 2024 and provided a corporate update.
